Loading...

Atrion Corporation

ATRINASDAQ
Healthcare
Medical - Instruments & Supplies
$459.92
$0.26(0.06%)

Atrion Corporation (ATRI) Stock Overview

Explore Atrion Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.9/100

Key Financials

Market Cap809.4M
P/E Ratio84.21
EPS (TTM)$7.13
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$261.70

ATRI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Atrion Corporation (ATRI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $261.70.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 84.21 and a market capitalization of 809.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;